Ping Hou

Shenyang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Causality of Childhood and Adult Body Mass Index on Sick Sinus Syndrome: A Mendelian Randomization Study.

Causality of Childhood and Adult Body Mass Index on Sick Sinus Syndrome: A Mendelian Randomization Study.

Journal: Cureus
Published: March 19, 2025

Antibody-Drug Conjugates (ADCs): current and future biopharmaceuticals.

Antibody-Drug Conjugates (ADCs): current and future biopharmaceuticals.

Journal: Journal of hematology & oncology
Published: December 26, 2024

The relationship between blood pressure and risk of atrial fibrillation: a combined and sex-stratified Mendelian randomization study.

The relationship between blood pressure and risk of atrial fibrillation: a combined and sex-stratified Mendelian randomization study.

Journal: Archives of medical science : AMS
Published: November 24, 2024

Evaluation of the Potential Targets of Shenxian-Shengmai Oral Liquid in Treating Sick Sinus Syndrome Based on Network Pharmacology and Molecular Docking.

Evaluation of the Potential Targets of Shenxian-Shengmai Oral Liquid in Treating Sick Sinus Syndrome Based on Network Pharmacology and Molecular Docking.

Journal: Food science & nutrition
Published: March 29, 2024

Yixin-Fumai granules modulate autophagy through the PI3K/AKT/FOXO pathway and lead to amelioration of aging mice with sick sinus syndrome.

Yixin-Fumai granules modulate autophagy through the PI3K/AKT/FOXO pathway and lead to amelioration of aging mice with sick sinus syndrome.

Journal: Immunity & ageing : I & A
Published: March 15, 2024

D-galactose causes sinoatrial node dysfunction: from phenotype to mechanism.

D-galactose causes sinoatrial node dysfunction: from phenotype to mechanism.

Journal: Aging
Published: August 01, 2023

Shenxian-Shengmai Oral Liquid Evoke Autophagy of Fibroblast to Attenuate Sinoatrial Node Fibrosis in Sick Sinus Syndrome Mice via the AKT/mTOR Pathway.

Shenxian-Shengmai Oral Liquid Evoke Autophagy of Fibroblast to Attenuate Sinoatrial Node Fibrosis in Sick Sinus Syndrome Mice via the AKT/mTOR Pathway.

Journal: Evidence-based complementary and alternative medicine : eCAM
Published: August 06, 2022

NRF-2/HO-1 Pathway-Mediated SHOX2 Activation Is a Key Switch for Heart Rate Acceleration by Yixin-Fumai Granules.

NRF-2/HO-1 Pathway-Mediated SHOX2 Activation Is a Key Switch for Heart Rate Acceleration by Yixin-Fumai Granules.

Journal: Oxidative medicine and cellular longevity
Published: April 22, 2022

Yixin-Fumai granules improve sick sinus syndrome in aging mice through Nrf-2/HO-1 pathway: A new target for sick sinus syndrome.

Yixin-Fumai granules improve sick sinus syndrome in aging mice through Nrf-2/HO-1 pathway: A new target for sick sinus syndrome.

Journal: Journal of ethnopharmacology
Published: April 14, 2021

Shenxian-Shengmai Oral Liquid Improves Sinoatrial Node Dysfunction through the PKC/NOX-2 Signaling Pathway.

Shenxian-Shengmai Oral Liquid Improves Sinoatrial Node Dysfunction through the PKC/NOX-2 Signaling Pathway.

Journal: Evidence-based complementary and alternative medicine : eCAM
Published: January 21, 2021

κ Opioid Receptor Agonist Inhibits Myocardial Injury in Heart Failure Rats through Activating Nrf2/HO-1 Pathway and Regulating Ca2+-SERCA2a.

κ Opioid Receptor Agonist Inhibits Myocardial Injury in Heart Failure Rats through Activating Nrf2/HO-1 Pathway and Regulating Ca2+-SERCA2a.

Journal: Oxidative medicine and cellular longevity
Published: May 14, 2020

Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF‑β1/Smad3 signaling pathway.

Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF‑β1/Smad3 signaling pathway.

Journal: Molecular medicine reports
Published: August 17, 2017
Showing 1-12 of 16

Last Updated: 09/26/2026